Follow the Coya Therapeutics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €98.3m. The latest transaction was reported on 19 August 2025 (Levée d'options). Among the most active insiders: GOLDSTEIN DOV A MD. Every trade is openly available.
13
Insider Decl.
n/a
Thresholds
€103,122
12 ops.
Buy Volume
n/a
n/a
Sell Volume
48Σ signal
Buys €103,122n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 sharesCommon Stock, par value $0.0001 per shareSEC:0001493152-23-000225:0
Canonical exit: 3 Apr 2023 (T+90)
13 of 13 declarations
About Coya Therapeutics, Inc.
Coya Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases. It concentrates on research and commercialization of treatments that enhance the quality of life for patients.